Global Human Milk Oligosaccharides (HMO) In-Depth Monitoring and Development Analysis Report 2023

Length- 108 Pages | Published Date - 2022-12-30 | Report Id- 3845
Single Licence $3850.00 | Enterprise License $6200.00 | Multiple Licensee $6200.00
In terms of market side, this report researches the Human Milk Oligosaccharides (HMO) revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.Global Human Milk Oligosaccharides (HMO) market size in 2022 is 229.51 million US dollars, and it is expected to be 861.53 million US dollars by 2029, with a compound annual growth rate of 20.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Human Milk Oligosaccharides (HMO) market include Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, and Dextra Laboratories Ltd.. The share of the top 3 players in the Human Milk Oligosaccharides (HMO) market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Human Milk Oligosaccharides (HMO) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. 2’FL accounted for XX% of Human Milk Oligosaccharides (HMO) market in 2022. 3’FL share of XX%.
Infant Formula accounted for XX% of the Human Milk Oligosaccharides (HMO) market in 2022. Functional Food & Beverage accounts for XX%.

Report Includes:
This report presents an overview of global market for Human Milk Oligosaccharides (HMO). Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Human Milk Oligosaccharides (HMO), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Milk Oligosaccharides (HMO) market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) sales, projected growth trends, technology, application and end-user industry.

Market Trend:
Increasing Demand: The demand for HMOs was growing due to their potential health benefits, including promoting healthy gut microbiota, enhancing immune function, and supporting cognitive development in infants. This demand was primarily driven by the rising awareness of the importance of nutrition in early childhood.

Infant Formula Industry: HMOs were being incorporated into infant formula products as an attempt to mimic the nutritional composition of breast milk and provide similar benefits. Several major infant formula manufacturers were investing in research and development to incorporate HMOs into their products.

Research and Development: Ongoing research and development activities were focused on exploring the potential health benefits of HMOs and finding cost-effective methods for large-scale production. As more scientific evidence emerged supporting the positive effects of HMOs, the market was expected to expand further.

Regulatory Landscape: Regulations regarding the use of HMOs in food and infant formula were evolving. Regulatory bodies were assessing the safety and efficacy of HMOs and establishing guidelines for their use. Compliance with these regulations played a crucial role in the market dynamics.

Competitive Landscape: The HMO market was becoming more competitive, with both established and emerging companies entering the space. Key players were investing in production capacity expansion and collaborations with research organizations to gain a competitive edge.

The Following is the Scope of Analysis Mainly Covered by Our Research on the Global {XX} Market:
Highlights-Regions
North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Latin America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Abbott Laboratories
BASF S.E.
Biosynth Carbosynth
Chr. Hansen Holding A/S
Dextra Laboratories Ltd.
Dupont Nutrition & Biosciences
Elicityl S.A.
Glycom A/S
Glycosyn
Inbiose NV
Medolac Laboratories
Neolacta Lifesciences Pvt. Ltd
Nestle Health Science
Royal DSM
Royal FrieslandCampina N.V.
ZuChem

Types list
2’FL
3’FL
3’SL
6’SL

Application list
Infant Formula
Functional Food & Beverage
Food Supplements

Contact US Anytime

Contact US Anytime

Find More

Global Human Milk Oligosaccharides (HMO) In-Depth Monitoring and Development Analysis Report 2023

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top
Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language

Sample Request

Message